Myriad Genetics, Vermillion Shares Up Sharply in February | GenomeWeb

NEW YORK (GenomeWeb News) – For the second month in a row, shares of Myriad Genetics rose sharply, pacing gainers in the GenomeWeb Daily News Index.

The GWDN Index climbed 5 percent in February, outpacing the Down Jones Industrial Average (+ 4 percent) and matching the Nasdaq (+ 5 percent) for the month. However, it trailed the Nasdaq Biotech Index, which gained 8 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.